CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it overcharged Medicare for prescription drugs.

A federal judge ordered CVS Health's Omnicare unit to pay $948.8 million in penalties and damages, in a whistleblower lawsuit ...

A federal judge has ordered CVS Health Corp.’s Omnicare Inc. unit to pay $949 million as part of a whistleblower lawsuit ...

The lawsuit was filed under the False Claims Act, which helps the government combat fraud and requires tripling of damages, ...

A New York judge has ordered CVS Health's Omnicare subsidiary to pay $948.8 million in fees and damages as part of a False ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

Pennsylvania — A huge whistleblower lawsuit has been filed against CVS Caremark, alleging it over billed the Government by hundreds of millions of dollars in an elaborate pricing scheme. And ...

Starting in 2015, a whistleblower lawsuit alleges CVS Health coordinated an effort that relied on its SilverScript subsidiary, its Caremark pharmacy benefits manager, ...

CVS Pharmacy allegedly fueled and profited from the opioid epidemic by repeatedly dispensing controlled substances without a legitimate medical purpose. Today, the United States Department of ...

CVS Caremark, the pharmacy benefit management division of Woonsocket, R.I.-based CVS Health, stands accused of improperly reporting Medicare generic drug prices to CMS, according to a STAT report.

By Jonathan Stempel (Reuters) -CVS Health’s pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it overcharged Medicare for prescription drugs.

Adding to allegations made in the whistleblower lawsuit, the DOJ complaint alleges that CVS Pharmacy knowingly filled millions of unlawful prescriptions for controlled substances that lacked a ...